How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease? A response to Grover et al

Diabetes Care. 2001 Jul;24(7):1306-7. doi: 10.2337/diacare.24.7.1306.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Diabetes Complications*
  • Diabetes Mellitus / physiopathology
  • Diabetes Mellitus / psychology
  • Female
  • Humans
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Male
  • Morbidity
  • Quality of Life
  • Quality-Adjusted Life Years*
  • Simvastatin / therapeutic use*

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Simvastatin